Myogenin - A more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1

Medical and Pediatric Oncology

Volumn 40, Issue 1, 2003, Pages 1-8

  Michelagnoli, Maria P ^a,b   Burchill, Susan A ^a   Cullinane, Catherine ^a   Selby, Peter J ^a   Lewis, Ian J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Low level disease; Minimal residual disease; MyoD1; Myogenin; Rhabdomyosarcoma; RT PCR

Indexed keywords

MYOD1 PROTEIN; MYOGENIN;

ADOLESCENT; ARTICLE; BLOOD; BONE MARROW; CANCER DIAGNOSIS; CHILD; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE DEVELOPMENT; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SARCOMA;

EID: 0037210159     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10201     Document Type: Article

References (37)

1. Wexler LH, Helman L. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology, 3rd Ed. Philadelphia: LippincottRaven; 1997. p 799-830.
2. Crist W, Gehan EA, Ragab AH, et al. The third intergroup rhabdomyosarcoma study. J Clin Oncol 1995;13:610-630.
3. Ruymann FB, Newton WA, Jr., Ragab AH, et al. Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. A report from the intergroup rhabdomyosarcoma study. Cancer 1984;53:368-373.
4. Michelagnoli MP, Hazel D, Devine T, et al. Life after relapse? A retrospective review of outcome. Med Pediatr Oncol 1998;31(4):205.
5. Fey MF, Kulozic AE, Hansen-Hagge TE, et al. The polymerase chain reaction: A new tool for the detection of minimal residual disease in haematological malignancies. Eur J Cancer 1991;27:89-94.
6. Kelly KM, Womer RB, Barr FG. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Cancer 1996;78:1320-1327.
7. Tsokos M. The diagnosis and classification of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994;11:26-38.
8. Patton RB, Horn RC. Rhabdomyosarcoma: Clinical and pathological features and comparison with human fetal and embryonal skeletal muscle. Surgery 1961;52:572-584.
9. Weintraub H, Davis R, Tapscott S, et al. The myoD gene family: Nodal point during specification of the muscle cell lineage. Science 1991;251:761-766.
10. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
11. Edmondson DG, Olson EN. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program [published erratum appears in Genes Dev 1990 Aug;4(8):14501. Genes Dev 1989;3:628-640.
12. Dias P, Parham DM, Shapiro DN, et al. Myogenic regulatory protein (MyoD1) expression in childhood solid tumours: Diagnostic utility in rhabdomyosarcoma. Am J Pathol 1990;137:1283-1291.
13. Tonin PN, Scrable H, Shimada H, et al. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Cancer Res 1991;51:5100-5106.
14. Wang NP, Marx J, McNutt MA, et al. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol 1995;147:1799-1810.
15. Cui S, Hano H, Harada T, et al. Evaluation of new monoclonal antiMyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol Int 1999;49:62-68.
16. Wyld DK, Selby P, Perren TJ, et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998;79:288-293.
17. Mattano LA, Jr., Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptasepolymerase chain reaction. Cancer Res 1992;52:4701-4705.
18. Datta YH, Adams PT, Drobyski WR, et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-482.
19. Gerhard M, Juhl H, Kalthoff H, et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-729.
20. Frascella E, Rosolen A. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction. Am J Pathol 1998;152:577-583.
21. Burchill SA, Bradbury MF, Pittman K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-281.
22. Burchill SA, Lewis IJ, Selby P. Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells. Br J Cancer 1999;79:971-977.
23. Fujisawa-Sehara A, Nabeshima Y, Hosoda Y, et al. Myogenin contains two domains conserved among myogenic factors. J Biol Chem 1990;265:15219-15223.
24. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.
25. Molenaar WM, Oosterhuis JW, Kamps WA. Cytologic "differentiation" in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol 1984;15:973-979.
26. Bouche M, Senni MI, Grossi AM, et al. TPA-induced differentiation of human rhabdomyosarcoma cells: Expression of the myogenic regulatory factors. Exp Cell Res 1993;208:209-217.
27. Lee SM, Knoppel E, van de Ven C, et al. Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3, and macrophage colonystimulating factor genes in activated cord versus adult mononuclear cells: Alteration in cytokine expression may be secondary to posttranscriptional instability. Pediatr Res 1993;34:560-564.
28. Sorensen PH, Triche TJ. Gene fusions encoding chimaeric transcription factors in solid tumours. Semin Cancer Biol 1996;7:3-14.
29. Ravinsky E, Safneck JR, Quinonez G, et al. Fine needle aspiration biopsy of a small round cell tumor exhibiting both neural and myogenic differentiation. A case report. Acta Cytol 1997;41:1320-1324.
30. Long AA. In-situ polymerase chain reaction: Foundation of the technology and today's options. Eur J Histochem 1998;42(2):101-109.
31. Lawrence W, Jr., Gehan EA, Hays DM, et al. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol 1987;5:46-54.
32. Rodary C, Flamant F, Donaldson SS. An attempt to use a common staging system in rhabdomyosarcoma: A report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 1989;17:210-215.
33. Johnson PW, Burchill SA, Selby PJ. The molecular detection of circulating tumour cells. Br J Cancer 1995;72:268-276.
34. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 1991;51: Suppl.5054s-5059s.
35. Fagnou C, Michon J, Peter M, et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing tumours. Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 1998;16(5):1707-1711.
36. Burchill SA, Bradbury FM, Selby P, et al. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Eur J Cancer 1995;31A:553-556.
37. Lawrence W, Jr., Hays DM, Heyn R, et al. Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study. Cancer 1987;60:910-915.